Table 1.
Schedule of enrolment, interventions and assessments.
| MDMS for IDA | Study period – 3 months | |||
|---|---|---|---|---|
| Consent | Allocation | Post-allocation | Close-out | |
| TIMEPOINT | 0 | 4 weeks | 3 months | |
| ENROLMENT: | ||||
| Eligibility screen | X | |||
| Informed consent | X | |||
| Allocation | X | |||
| INTERVENTION: MDMS |
|
|||
| ASSESSMENTS: | ||||
| Primary outcome | ||||
| Change in HbA1c | X | X | ||
| Secondary outcomes | ||||
| Serum fructosamine, patient satisfaction survey, | X | X | ||
| Patient acceptability of MDMS survey | X | |||
| Self-reported hypoglycaemic events survey | X | X | X | |
| Healthcare provider (CDE) satisfaction survey | X | |||
| Completion rate of IDA | X | |||
| Clinician time, diabetes-related visits to CDE/GP/hospital |
|
|||
CDE, credentialed diabetes educator; GP, general practitioner; HbA1c, glycated haemoglobin; IDA, insulin dose adjustment; MDMS, mobile diabetes management system.